Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide-Reference-Cited by-同舟云学术

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Published:2017-01-06 Issue:4 Volume:1 Page:288-292
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Kasamon Yvette L.¹,Ambinder Richard F.¹,Fuchs Ephraim J.¹,Zahurak Marianna¹,Rosner Gary L.¹,Bolaños-Meade Javier¹,Levis Mark J.¹,Gladstone Douglas E.¹,Huff Carol Ann¹,Swinnen Lode J.¹,Matsui William H.¹,Borrello Ivan¹,Brodsky Robert A.¹,Jones Richard J.¹,Luznik Leo¹

Affiliation:

1. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD

Abstract

Key Points Nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide carries an acceptable safety profile. This platform may expand the donor pool for patients who lack an HLA-matched or -haploidentical donor.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/1/4/288/878026/advances002766.pdf

Reference25 articles.

1. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide;McCurdy;Blood,2015

2. Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors;Kanate;Blood,2016

3. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia;Ciurea;Blood,2015

4. Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: A Center for International Blood and Marrow Transplant Research analysis;Ghosh;J Clin Oncol,2016

5. Cord-blood transplantation in patients with minimal residual disease;Milano;N Engl J Med,2016

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors;Journal of Clinical Oncology;2024-07-17

2. Haploidentical vs. mismatched unrelated donor transplants with posttransplant cyclophosphamide-based GVHD prophylaxis;Bone Marrow Transplantation;2024-05-22

3. Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort;Transplantation and Cellular Therapy;2024-05

4. Haploidentical vs Mismatched Unrelated Donor Transplants with Posttransplant Cyclophosphamide-based GVHD Prophylaxis;2024-02-16

5. Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor;Bone Marrow Transplantation;2024-02-08